NGHS Continuing Medical Education

NGHS Continuing Medical Education We are committed to providing quality medical education to physicians.

🩺 STI Awareness Month: Know Your Status. Protect Your Health.STIs are on the rise—but the good news is that testing, tre...
04/22/2026

đź©ş STI Awareness Month: Know Your Status. Protect Your Health.

STIs are on the rise—but the good news is that testing, treatment, and prevention are more accessible than ever. This STI Awareness Month, we’re highlighting the importance of early detection and informed care.

🔍 What you should know:
✅ Regular testing is key—even without symptoms
âś… Many STIs are treatable and outcomes improve with early care
âś… Partner services help prevent further spread
âś… Community resources make care more accessible and affordable

Taking action protects not just you—but your community.

04/21/2026

One of the biggest challenges in long-term care is helping patients and families understand that altered mental status alone does not automatically mean a UTI.

Current evidence shows that urine testing should not be done by default unless there are additional signs and symptoms of infection. Testing without clear indications can lead to misdiagnosis and unnecessary treatment.

This is where antimicrobial stewardship plays a critical role. Developing clear protocols, ensuring the right indication for testing, obtaining the correct urine sample, and ordering the appropriate test all help protect patients and improve the quality of care.

Watch the full podcast: https://www.youtube.com/watch?v=kpLndmo2amY&t=525s

04/16/2026

Did you know that severe asymptomatic hypertension is no longer treated the same way it used to be?

New evidence shows that acute blood pressure lowering offers no proven benefit for patients without symptoms—even when readings are extremely high. Instead of short-acting medications, current guidance emphasizes chronic outpatient management using long-term antihypertensive therapy.

Key takeaway from IM Grand Rounds:
Blood pressure is a chronic disease, not an emergency unless there’s end-organ damage.

This shift highlights how evidence-based medicine continues to refine how we care for patients—focusing on outcomes, not just numbers.

Watch the full presentation: https://www.youtube.com/watch?v=w4G-T2MxGRA

04/14/2026

Colon and re**al cancer rates are increasing in younger adults—and it’s raising serious concerns in the medical community.

Symptoms like re**al bleeding should never be automatically dismissed as hemorrhoids. Early screening, family history awareness, and proactive follow-up can save lives.

If something doesn’t feel right, ask questions. Early detection matters.

Watch the full presentation: https://www.youtube.com/watch?v=-5T5OqbhPQ0




04/09/2026

High blood pressure during pregnancy isn’t just a routine finding—it can be a critical warning sign. In this Grand Rounds discussion, clinicians explain how hypertension is defined differently in pregnancy and when it’s classified as chronic versus gestational.

The conversation also highlights why treatment thresholds matter and how maintaining the appropriate blood pressure range helps protect both mother and baby.

In addition, experts discuss peripartum cardiomyopathy, a rare but serious form of heart failure that can develop late in pregnancy or shortly after delivery.

Symptoms such as shortness of breath at rest, swelling in the legs, difficulty lying flat, and fluid in the lungs may feel common during pregnancy—but they shouldn’t be ignored. Early recognition and awareness can make all the difference.
Watch the full presentation: https://www.youtube.com/watch?v=9RvRENsdx5I&t=50s

04/07/2026

Not every patient needs a reflex urinalysis or culture at triage.
By collecting and holding urine instead of automatically testing it, clinicians can wait until the provider evaluates the patient and determines whether a urinalysis or culture is truly clinically indicated.

This small workflow change helps reduce unnecessary testing, improves decision-making, and supports better patient care.

- Less reflex testing
- More clinical judgment
- Smarter protocols

Watch the full podcast: https://www.youtube.com/watch?v=kpLndmo2amY&t=27s

04/02/2026

Over the last five years, groundbreaking clinical trials have reshaped how we manage atrial fibrillation (AFib). What we believed two decades ago no longer applies.

Today’s focus has shifted toward rhythm control, supported by safer, more effective technologies. From cardioversion to catheter ablation, more patients than ever are now candidates for procedures that help restore and maintain a normal heart rhythm—improving long-term outcomes and quality of life.

This is a major paradigm shift in AFib care, and it’s changing how we treat patients for the better.
Watch the full presentation: https://www.youtube.com/watch?v=V5Fy2hEIUBg&t=219s


03/31/2026

Inflammation isn’t just what causes redness or tenderness on the skin—it plays a powerful role inside our blood vessels too.

When inflammation begins in the vessel wall, it triggers a cascade of immune responses, including the release of interleukins and recruitment of inflammatory cells. Combined with lipid buildup, this process leads to platelet aggregation and narrowing of the blood vessels—key steps in the development of atherosclerosis.

It’s not just high cholesterol alone. Understanding inflammation helps us understand why cardiovascular disease develops and how early processes set the stage long before symptoms appear.

Knowledge is prevention.
Watch the full presentation: https://www.youtube.com/watch?v=eY70yZ2sWR4

03/27/2026

Thoracic Outlet Syndrome (TOS) isn’t a one-size-fits-all diagnosis. There are three primary types—arterial, venous, and neurogenic—and each follows a different path to diagnosis and treatment.

While vascular forms of TOS may be identified within months, neurogenic TOS can take years to diagnose, often delaying relief for patients. Across all types, treatment is driven by one key issue: compression.

In most cases, first rib resection plays a central role in management. Depending on the specific anatomy and symptoms, surgeons may also consider scalene muscle release or pectoralis minor release to restore space and function.

Today’s Surgery Grand Rounds highlighted how understanding these differences is critical to improving outcomes and shortening the road to diagnosis.
Watch the full presentation: https://www.youtube.com/watch?v=rGQ-7i1iCHQ

March is National Colore**al Cancer Awareness Month.This CME session highlights evolving, personalized approaches to re*...
03/25/2026

March is National Colore**al Cancer Awareness Month.

This CME session highlights evolving, personalized approaches to re**al cancer treatment, focusing on clinical decision‑making and patient‑centered care.

🎥 Personalizing Re**al Cancer Treatment

Link in comments.

**alCancerAwareness **alCancer

03/23/2026

In post‑acute and long‑term care, 50% of women and 40% of men will have asymptomatic bacteriuria. That doesn’t mean they need antibiotics.

Treating when there are no symptoms sets off a dangerous cascade—C. diff infections, multidrug‑resistant organisms, and increased spread in long‑term care settings.

It all starts with good practice from the beginning.
Let’s stop unnecessary treatment and protect our patients and communities.
Watch the full Podcast: https://www.youtube.com/watch?v=kpLndmo2amY&t=25s

03/19/2026

Curious about what actually leads to inflammation and atherosclerosis? During this week’s Grand Rounds, we explored how cholesterol particles like LDL, VLDL, and IDL contribute to cardiovascular disease, especially through the ApoB ligand carried on all of these molecules.

This ApoB component plays a significant role in driving inflammation and helping plaque form in the arteries. While medications can lower ApoB, attempts to directly target it—such as with antibodies—haven’t been successful and, in some cases, caused harm to patients.

We also discussed Lipoprotein(a), or Lp(a), a newer and increasingly recognized marker of cardiovascular risk. Unfortunately, there are very few therapies available today that effectively reduce Lp(a).

PCSK9 inhibitors can provide modest reductions, but for most people, Lp(a) levels are largely determined by genetics. Researchers are now working on new treatments designed specifically to target Lp(a), with the hope of reducing long‑term cardiovascular disease risk.

Heart health research continues to evolve quickly, and we look forward to sharing more insights from future Grand Rounds sessions.
Watch the full presentation: https://www.youtube.com/watch?v=d70Gv2TgRrI&t=1s

Address

743 Spring Street SE
Gainesville, GA
30501

Website

Alerts

Be the first to know and let us send you an email when NGHS Continuing Medical Education posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category